A
blended strain capsule, softgel product produced in Ontario by
Aspire using CO2 extraction in the Cannabis Extracts category with 74% Lower THC* potency at
2.0% and NO CBD content. Includes 67% Lower CBG* content at
6.0% (* based on average potencies for Capsules, Softgels).
Using available terpene and strain data, we find Halo Lift 3:1 CBG/THC to have a
2/10 score for aid with
inflammation** including help with
infection, and overall
product score (ePS) of
1/10 when compared to products in the same category.
Highs include: Reduced THC content for category; Includes CBG
✦. Noted observations: Nominal CBG content for category.